Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$1.63B
-
Value change
-
+$43.2M
-
Put/Call ratio
-
0.14
-
Number of buys
-
78
-
Number of sells
-
-66
-
Price
-
$30.64
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2020
178 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
of 87M outstanding shares and own 61.09% of the company stock.
Largest 10 shareholders include FMR LLC (7.24M shares), EcoR1 Capital, LLC (4.61M shares), BlackRock Inc. (4.38M shares), VANGUARD GROUP INC (2.67M shares), Avoro Capital Advisors LLC (2.44M shares), CITADEL ADVISORS LLC (2.13M shares), STATE STREET CORP (1.73M shares), VICTORY CAPITAL MANAGEMENT INC (1.7M shares), EAGLE ASSET MANAGEMENT INC (1.5M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.5M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.